Clinical Trial Update: Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia [Phase 3]

View source ↗

Summary

Phase 3 trial update for Almorexant (ACT-078573) in adults with chronic primary insomnia; the study completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Almorexant (ACT 078573)

Snippet

Sponsor: Midnight Pharma, LLC | Conditions: Primary Insomnia | Phase 3 | Status: COMPLETED | Results posted: 2013-02-07